Veterinary Medicines Information website

Nobivac DHPPi vet. injektiokuiva-aine ja liuotin, suspensiota varten

Authorised
  • Canine parainfluenza virus, strain Cornell, Live
  • Canine parvovirus, strain 154, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Canine distemper virus, strain Onderstepoort, Live
Download as PDF

Product identification

Medicine name:
Nobivac DHPPi vet. injektiokuiva-aine ja liuotin, suspensiota varten
Active substance:
  • Canine parainfluenza virus, strain Cornell, Live
  • Canine parvovirus, strain 154, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Canine distemper virus, strain Onderstepoort, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parainfluenza virus, strain Cornell, Live
    5.50
    log10 50% tissue culture infectious dose
    /
    1.00
    dose
  • Canine parvovirus, strain 154, Live
    7.00
    log10 50% tissue culture infectious dose
    /
    1.00
    dose
  • Canine adenovirus 2, strain Manhattan LPV3, Live
    4.00
    log10 50% tissue culture infectious dose
    /
    1.00
    dose
  • Canine distemper virus, strain Onderstepoort, Live
    4.00
    log10 50% tissue culture infectious dose
    /
    1.00
    dose
Pharmaceutical form:
  • Powder and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Finland
Available in:
  • Finland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 13483
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 18/12/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 18/12/2025
Download